نتایج جستجو برای: small cell lung cancer
تعداد نتایج: 3069991 فیلتر نتایج به سال:
Background: Immune checkpoint inhibitors (ICIs) have become the standard treatment for patients with advanced non-small cell lung cancer (NSCLC). However, safety and efficacy of ICIs in severe NSCLC poor performance status (PS) are still unclear.
Lung cancer is still the main cause of death in cancer diseases, both in men and women. The high incidence and poor prognosis of the lung cancer makes it a major health priblem in the last few decades. Determination of frequency of different histopathologic types of primary lung cancer has great importance in creating integrated treatment programs and to recognize the effective factors causin...
Erlotinib (ELT) as a small molecule with poor solubility, poor bioavailability, and instability in gastrointestinal environment, has been considered as a therapeutic agent for Non-Small-Cell Lung Cancer (NSCLC) therapy through oral administration. In the present study, ELT-liposome and ELT-NLCs were successfully prepared and characterized by assessment of the particle size, zeta potential (ZP),...
Erlotinib (ELT) as a small molecule with poor solubility, poor bioavailability, and instability in gastrointestinal environment, has been considered as a therapeutic agent for Non-Small-Cell Lung Cancer (NSCLC) therapy through oral administration. In the present study, ELT-liposome and ELT-NLCs were successfully prepared and characterized by assessment of the particle size, zeta potential (ZP),...
background: lung cancer is considered as one of the most frequent cancers worldwide, and has been the cause of more than onemillion mortalities each year. exposure to tobacco smoke is the primary cause of most lung cancers, since it contains several thousandcompounds, including more than 50 known carcinogens. however, a small fraction of individuals who are exposed to tobacco smokedevelop lung ...
Lung Cancer has become a global health burden in the past years due to being second largest contributor new cases and high mortality rates worldwide which is around 1.8 million patients. There are two main histological groups of Cancer, however non-small cell lung cancer more prevalent composed three histologic subtypes adenocarcinoma represents highest prevalence. It calculated that incidence ...
OBJECTIVES The aim of this study was to compare the expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in small cell lung cancer and subtypes of non-small cell lung cancer and examine their relationships with clinicopathologic factors, response to treatment and survival. METHODS We examined samples obtained by bronchial endoscopic biopsy from 55 patients with ino...
Testing for driver mutations in non-squamous non-small cell lung cancer (NSCLC) before treatment is recommended. Next Generation Sequencing (NGS) allows simultaneous testing of multiple genes. NGS results NS-NSCLC Lebanon have not yet been reported.
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید